Cellectis (CLLS) PT Lowered to $8 at Baird
Tweet
Share
E-mailGet Alerts CLLS Hot Sheet
Price: $1.53 +4.79%
Rating Summary:
10 Buy, 5 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
10 Buy, 5 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
Baird analyst Madhu Kumar lowered the price target on Cellectis (NASDAQ: CLLS) to $8.00 (from $10.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Barclays Double Downgrades Cellectis (CLLS) to Underweight
- Trip.com Group Ltd (9961:HK) (TCOM) PT Lowered to HK$490 at JPMorgan
- China Cinda Asset Management (1359:HK) PT Lowered to HK$0.95 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
